EpitalON is not approved as a medicine in the UK or EU
Synthetic peptide derived from body-protective protein
Early multiorgan failure, thrombosis, intracranial (superior sagittal sinus) hypertension, portal and caval hypertension, and aortal hypotension, in its full presentation (i.e., giant T-wave) or attenuated by BPC 157 therapy (i.e., normal T-wave) may be decisive for further isoprenaline-lesion development, similar to that noted with major intoxication (i.e., alcohol, lithium) or major vessel occlusion [14,15,16,17,18,19,20,21,22,23]
It exerts its effects primarily within the tissue microenvironment at or near the site of injury
6b), were expressed and purified from approximately 800 mL of Sf9 cells each under the same conditions as outlined for the full shelterin complex
Results often last up to a year